Read + Share
Amedeo Smart
Independent Medical Education
Perreault S, Cote R, Dragomir A, White-Guay B, et al. Effectiveness and safety of low-dose versus standard-dose rivaroxaban and apixaban in patients with atrial fibrillation. PLoS One 2022;17:e0277744.PMID: 36454798
Email
LinkedIn
Facebook
Twitter
Privacy Policy